The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The latest RBA interest rate decision is out, and the central bank has delivered another pause. The national cash rate remains at 4.35%.

The move had been widely anticipated by all of Australia’s big 4 banks, as well as investment bank analysts at Morgan Stanley, Citigroup and UBS.

Morgan Staley see the next meeting – in August, under the RBA’s 2024 meeting calendar – as posing a distinct risk of a rate rise.

Markets will now turn towards digesting the RBA minutes, but at this point, the story is pretty familiar to traders. We might get a cut later this year, but a lot of firms are calling early 2025.

As for the ASX, if there’s a widespread caution that the RBA could raise, it wasn’t obvious on the bourse.

The ASX200 posted its best gains in two weeks on Tuesday, up 0.9% to kick off lunchtime. All sectors were in the green.

Many analysts had been calling a November rate rise, but ANZ, long in Camp November, recently pushed out its forecast to early 2025. No shortage of counterparts have followed.

Markets in the US are divided on whether the US will cut this year in September or closer to Christmas. However, a 2024 cut is being priced in far stronger for the United States than what is the case down under.

More From The Market Online
The Market Online Video

ASX Market Close: Bourse finishes week on a high as Wisetech pummeled | November 22, 2024

The ASX200 closed up 0.85% at 8,393 points. Economists increasingly expect interest rates in Australia won’t…
The Market Online Video

HotCopper Highlights: Your most watched stocks for Week 47, 2024

In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing,…
Nuclear explosion mushroom cloud concept

Week 47 Wrap: HotCopper users’ most watched; Brent lifts on Putin’s scary letter; RFK dents CSL

Welcome to the end of another week. Let's start with what HotCopper users have been watching…
Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Dale Gillham’s weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in th…